BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29088752)

  • 1. CyclinD1 and p57
    Ru Y; Chen XJ; Zhao ZW; Zhang PF; Feng SH; Gao Q; Gao SG; Feng XS
    Oncotarget; 2017 Sep; 8(43):73860-73870. PubMed ID: 29088752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p57kip2, Rb protein and PCNA and their relationships with clinicopathology in human pancreatic cancer.
    Yue H; Na YL; Feng XL; Ma SR; Song FL; Yang B
    World J Gastroenterol; 2003 Feb; 9(2):377-80. PubMed ID: 12532471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between expression of p57(kip2), cyclin E protein, PCNA, and clinicopathological factors in human pancreatic cancer].
    Yue H; Zhang N; Feng XL; Ma SR; Song FL; Yang M; Tang YH
    Ai Zheng; 2003 Jul; 22(7):705-9. PubMed ID: 12866960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of P57(kip2) and cyslinE proteins in human pancreatic cancer.
    Yue H; Yu J; Zhao X; Song F; Feng X
    Chin Med J (Engl); 2003 Jun; 116(6):944-6. PubMed ID: 12877813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cell cycle regulator p57kip2, cyclinE protein and proliferating cell nuclear antigen in human pancreatic cancer: an immunohistochemical study.
    Yue H; Jiang HY
    World J Gastroenterol; 2005 Aug; 11(32):5057-60. PubMed ID: 16124066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expressions of cyclin E, cyclin dependent kinase 2 and p57(KIP2) in human gastric cancer.
    Liang B; Wang S; Yang X; Ye Y; Yu Y; Cui Z
    Chin Med J (Engl); 2003 Jan; 116(1):20-3. PubMed ID: 12667381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of C/EBP homologous protein (CHOP) expression in gastric cardia adenocarcinoma: Their relationship with clinicopathological parameters and prognostic significance.
    Zhu XJ; Gao SG; Li SQ; Shi ZG; Ma ZK; Zhu SS; Feng XS
    Clin Res Hepatol Gastroenterol; 2015 Jun; 39(3):391-8. PubMed ID: 25582300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
    Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
    Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does cyclin E and p57
    Ozgur T; Sumbul AT; Yaldız M; Temiz M; Akdağ A
    Int J Clin Exp Pathol; 2018; 11(8):3867-3875. PubMed ID: 31949774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p57(kip2) and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma.
    Nan KJ; Guo H; Ruan ZP; Jing Z; Liu SX
    World J Gastroenterol; 2005 Feb; 11(8):1237-40. PubMed ID: 15754413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Skp2/Low p57(Kip2) Expression is Associated with Poor Prognosis in Human Breast Carcinoma.
    Yang C; Nan H; Ma J; Jiang L; Guo Q; Han L; Zhang Y; Nan K; Guo H
    Breast Cancer (Auckl); 2015; 9(Suppl 1):13-21. PubMed ID: 26309408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of decorin and p57(KIP2) correlates with poor survival and lymphatic metastasis in lung cancer patients.
    Biaoxue R; Xiguang C; Hua L; Hui M; Shuanying Y; Wei Z; Wenli S; Jie D
    Int J Biol Markers; 2011; 26(1):9-21. PubMed ID: 21360479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p57(kip2) expression is related to carcinogenesis and tumor progression in laryngeal tissues.
    Fan GK; Xu F; Yang B; Fujieda S
    Acta Otolaryngol; 2006 Mar; 126(3):301-5. PubMed ID: 16618659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer.
    Puhalla H; Wrba F; Kandioler D; Lehnert M; Huynh A; Gruenberger T; Tamandl D; Filipits M
    Anticancer Res; 2007; 27(3B):1679-84. PubMed ID: 17595796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and significance of P57(kip2) and Maspin in pathological scar].
    Cai YM; Zhu SZ; Zheng ZF; Yang WQ; Wu WY
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Nov; 27(6):431-6. PubMed ID: 22292406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of p57Kip2 induces prostate cancer in the mouse.
    Jin RJ; Lho Y; Wang Y; Ao M; Revelo MP; Hayward SW; Wills ML; Logan SK; Zhang P; Matusik RJ
    Cancer Res; 2008 May; 68(10):3601-8. PubMed ID: 18483241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation-mediated repression of GADD45A and GADD45G expression in gastric cardia adenocarcinoma.
    Guo W; Dong Z; Guo Y; Chen Z; Kuang G; Yang Z
    Int J Cancer; 2013 Nov; 133(9):2043-53. PubMed ID: 23616123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
    Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
    Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Roles of p57KIP2 immunohistochemistry and flow cytometry in diagnosis of molar pregnancy].
    Yang SM; You JF; Zhang XW; Zheng J; Liao SL
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):580-4. PubMed ID: 20079184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues.
    Fan GK; Chen J; Ping F; Geng Y
    Oral Oncol; 2006 Feb; 42(2):147-53. PubMed ID: 16246616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.